8-K/A XBRL

FORM 8-K/A

Company: Cartesian Therapeutics, Inc.
Filed: January 23, 2024
Period of Report: November 13, 2023
Accession Number: 0001140361-24-003407

View Document ↗ View on SEC.gov ↗